Hormonal Regulation of Systolic Blood Pressure in Response to the GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist, Liraglutide.
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2015
At a glance
- Drugs Liraglutide (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms BOLT
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2015 The primary endpoints have been amended, according to ClinicalTrials.gov record.
- 24 Mar 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.